Patients Say The Borgess Patient Portal Login Is Very Secure
参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
Patient Portal App | Healthcare Services in IL & IN
